Author response for 'Meta‐Analysis of Head‐to‐Head Clinical trials Comparing Incretin‐Based Glucose‐Lowering Medications and Basal Insulin – An Update Including Recently Developed GLP ‐1 Receptor Agonists and the GIP / GLP ‐1 Receptor Co‐Agonist Tirzepatide'
| Autor: | null Michael A. Nauck, null Mirna Abd El Aziz, null Daniel R. Quast |
|---|---|
| Rok vydání: | 2023 |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|